Clinical studies recruiting near Udine

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Neurosurgical Outcome Network
Phase N/A · Azienda Sanitaria Universitaria Friuli Centrale di Udine · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06724029 Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
Phase 3 · Asui Di Udine - Presidio Ospedaliero "Santa Maria Della Mise · Gruppo Italiano Malattie EMatologiche dell'Adulto · NCT04168502 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Santa Maria della Misericordia · Regeneron Pharmaceuticals · NCT06091865 Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced S
Phase 1/Phase 2 · A.O. Santa Maria della Misericordia · ModernaTX, Inc. · NCT05533697 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · P.O. "S. Maria della Misericordia" Azienda Sanitaria Univers · Merck Sharp & Dohme LLC · NCT06077760 Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational Study From FIL_FOLL12 Trial
Phase N/A · Azienda Sanitaria Universitaria Friuli Centrale (ASU FC), SO · Fondazione Italiana Linfomi - ETS · NCT05816850 Salivary microRNA in Endometriosis: Correlation With Response to Progestin Therapy
Phase N/A · University of Udine · University of Udine · NCT06414720 Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy
Phase 3 · Udine - Azienda Sanitaria Universitaria Friuli Centrale (ASU · Fondazione Italiana Linfomi - ETS · NCT04442412 Sequential Therapies After Osteoanabolic Treatment
Phase N/A · University-Hospital S. Maria della Misericordia · 424 General Military Hospital · NCT06164795 A Global Prospective Observational Registry of Patients With Pompe Disease
Phase N/A · Regional Coordinating Centre for Rare Diseases, university H · Amicus Therapeutics · NCT06121011 HOPE Against Cancer Recurrence in HCC
Phase 4 · University of Udine · Philipp Dutkowski · NCT06717919 Multicentre Prospective Observational Study of Acute Intoxications in Paediatric Age
Phase N/A · Clinica Pediatrica Udine · Meyer Children's Hospital IRCCS · NCT06291649 CACP: Study on Camptodactyly - Arthropathy - Coxa Vara - Pericarditis (CACP) Syndrome
Phase N/A · Centro di Reumatologia Pediatrica · Meyer Children's Hospital IRCCS · NCT07468461 Observational Study on the Use of Ultrasound to Recognize Superficial Endometriosis in a Specific Area of the Pelvis (th
Phase N/A · Presidio ospedaliero-universitario Santa Maria della Miseric · Casa di Cura Dott. Pederzoli · NCT07427849 Volrustomig Priming Regimens Exploratory Phase II Platform Study
Phase 2 · Research Site · AstraZeneca · NCT06448754 Epidemiological Study on Invasive Bacterial Diseases
Phase N/A · Azienda sanitaria universitaria Friuli Centrale (ASU FC) · Meyer Children's Hospital IRCCS · NCT06322290 Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma
Phase N/A · Azienda sanitaria universitaria Friuli Centrale, Piazzale Sa · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06806579 A Study of Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis (MF) Who Are Unresponsive to JAK I
Phase 1/Phase 2 · Azienda Sanitario Universitaria Friuli Centrale · iOnctura · NCT06887803 A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Ly
Phase N/A · Azienda Sanitaria Universitaria Friuli Centrale (ASU FC) - S · Fondazione Italiana Linfomi - ETS · NCT06008691 A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants Wi
Phase 3 · Research Site · AstraZeneca · NCT05211895 Integrated Approach in Frail Older People with Atrial Fibrillation
NA · Pou "Santa Maria Della Misericordia"-S.O.C. Cardiologia · Heart Care Foundation · NCT06775028 Prehospital Management of Hypotensive Trauma in HEMS
Phase N/A · Udine FVG · Azienda Usl di Bologna · NCT04760977 Measure of Outcomes in Patients With Advanced Ovarian Cancer According to Homologous Recombination Status and Matched Th
Phase N/A · Azienda sanitaria universitaria Friuli Centrale (ASU FC) · Consorzio Oncotech · NCT06836219 A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06847867 OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Phase 3 · Clinical Trial Site · Olema Pharmaceuticals, Inc. · NCT06016738 EFESO: Study on Juvenile Onset Eosinophilic Fasciitis
Phase N/A · Università di Udine · Meyer Children's Hospital IRCCS · NCT07348263 Global Trial in APG2575 for Patients With CLL/SLL
Phase 3 · Ascentage Investigative Site · Ascentage Pharma Group Inc. · NCT06104566 Prevention ICONA Dedicated Ensemble
Phase N/A · Azienda Ospedaliera Universitaria Friuli Centrale (ASU FC) S · Fondazione ICONA · NCT07186244 A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in
Phase 3 · Azienda Sanitaria Universitaria Integrata di Udine · Nordic Lymphoma Group · NCT04332822

Look up another city

Look up another condition